Title |
Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study
|
---|---|
Published in |
Critical Care, August 2009
|
DOI | 10.1186/cc7990 |
Pubmed ID | |
Authors |
Andrea Morelli, Christian Ertmer, Sebastian Rehberg, Matthias Lange, Alessandra Orecchioni, Valeria Cecchini, Alessandra Bachetoni, Mariadomenica D'Alessandro, Hugo Van Aken, Paolo Pietropaoli, Martin Westphal |
Abstract |
Recent clinical data suggest that early administration of vasopressin analogues may be advantageous compared to a last resort therapy. However, it is still unknown whether vasopressin and terlipressin are equally effective for hemodynamic support in septic shock. The aim of the present prospective, randomized, controlled pilot trial study was, therefore, to compare the impact of continuous infusions of either vasopressin or terlipressin, when given as first-line therapy in septic shock patients, on open-label norepinephrine requirements. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 50% |
United States | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 5 | 2% |
United Kingdom | 3 | 1% |
Turkey | 1 | <1% |
Colombia | 1 | <1% |
Spain | 1 | <1% |
Unknown | 203 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 35 | 16% |
Student > Postgraduate | 28 | 13% |
Other | 27 | 13% |
Student > Ph. D. Student | 22 | 10% |
Student > Doctoral Student | 21 | 10% |
Other | 55 | 26% |
Unknown | 26 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 156 | 73% |
Agricultural and Biological Sciences | 6 | 3% |
Social Sciences | 6 | 3% |
Nursing and Health Professions | 4 | 2% |
Unspecified | 3 | 1% |
Other | 12 | 6% |
Unknown | 27 | 13% |